Lead Sponsor

Oxford University Hospitals NHS Trust

Collaborators

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

•Participant is willing and able to give informed consent for participation in the study.
•Male or Female, aged 18 years or above.
•Histological diagnosis of primary cutaneous invasive melanoma (any Breslow thickness) at 3 - 12 months from diagnosis (as most primary treatment will be complete by 3 mths)
•American Joint Cancer Committee Version 8 \[2018\] (AJCC V8) Stage I - III melanoma at time of recruitment
•Able to complete an electronic questionnaire

•Other current active internal malignancy (i.e. does not include non-melanoma skin cancers)
•Inability to independently complete electronic questionnaire
•AJCC V8 Stage IV melanoma at time of recruitment
•Clinical stage of disease unknown / unconfirmed